Disease Prevention and Alleviation by Human Myoblast Transplantation

ISSN Print: 2169-2513
ISSN Online: 2169-2521
www.scirp.net/journal/ojrm
E-mail: [email protected]

Citations

"Disease Prevention and Alleviation by Human Myoblast Transplantation"
written by Peter K. Law,
published by Open Journal of Regenerative Medicine, Vol.5 No.2, 2016

has been cited by the following article(s):

[1]	Human Myoblast Genome Therapy and the Regenerative Heart
	… Applications of Stem …, 2023

[2]	Genetic Cell Therapy in Anti-Aging Regenerative Cosmetology
	Handbook of Stem Cell …, 2023

[3]	Myoblast Therapies Constitute a Safe and Efficacious Platform Technology of Regenerative Medicine for the Human Health Industry
	2022

[4]	System Engineering of Emergent Serum Therapy to Combat COVID-19 and Other Pathogenic Pandemics
	2020

[5]	COVID-19 Pandemic: Its Origin, Implications and Treatments
	2020

[6]	World's First Myoblast Treatment of Human Cancer Found Safe and Efficacious
	2017

[7]	Crime against Humanity—Uncovering Two Decades of Corruption in the FDA Regarding DMD Treatment
	2017

[8]	Scientific Research
	2017

[1]	Genetic Cell Therapy in Anti-Aging Regenerative Cosmetology Open Journal of Regenerative Medicine, 2023 DOI:10.4236/ojrm.2023.121001

[2]	Handbook of Stem Cell Therapy 2022 DOI:10.1007/978-981-16-6016-0_34-1

[3]	COVID-19 Pandemic: Its Origin, Implications and Treatments Open Journal of Regenerative Medicine, 2020 DOI:10.4236/ojrm.2020.92006

[4]	World’s First Myoblast Treatment of Human Cancer Found Safe and Efficacious Open Journal of Regenerative Medicine, 2017 DOI:10.4236/ojrm.2017.61001

[5]	Crime against Humanity —Uncovering Two Decades of Corruption in the FDA Regarding DMD Treatment Open Journal of Regenerative Medicine, 2017 DOI:10.4236/ojrm.2017.64004

Top